Drug intelligence / Profile preview

Liwei Capsule

Development stage: Unknown
Lead developer: Jianmin Pharmaceutical Group
Administration: Oral

Overview

Liwei Capsule (利胃胶囊) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Hebei Province Cangzhou Tangsheng Pharmaceutical. It is formulated to treat gastric conditions, specifically chronic non-atrophic gastritis with erosion. The medication is designed to harmonize the stomach and alleviate epigastric pain. In clinical development, it has been studied in Phase 3 trials (such as CTR20180969) to evaluate its efficacy in resolving symptoms of epigastric pain over a 28-day treatment course, often compared against other TCM gastric treatments like Sanjiu Weitai Capsule.

Brand names: Liwei CapsuleLiwei
Other names: 利胃胶囊Liwei Jiaonang

Beyond the preview

Go deeper on Liwei Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Liwei Capsule.

Explore the full profile